FDA Inspection 961640 — Seattle Reproductive Medicine, Inc., P.S.
The FDA completed an inspection of Seattle Reproductive Medicine, Inc., P.S. on Feb 10, 2016 in Bellevue, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 10, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Bellevue, WA (United States)